Effects of olanzapine on glucose and lipidmetabolism, liver function and prolactin in childhood onset schizophrenia
10.3969/j.issn.1671-8348.2017.09.013
- VernacularTitle:奥氮平对儿童精神分裂症患者糖脂代谢、肝功能及泌乳素的影响
- Author:
Kefeng LIU
;
Xin TIAN
;
Wenhua XUE
;
Jie ZHAO
- Keywords:
olanzapine;
schizophrenia,childhood;
glucolipid metabolism;
liver function;
prolactin
- From:
Chongqing Medicine
2017;46(9):1193-1195
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effects of olanzapine on glucolipid metabolism,liver function and prolactin level in childhood onset schizophrenia(COS) to provide reference for clinical medication.Methods Thirty-eight patients with COS aged 13-17 years old were treated with olanzapine for at least two weeks.The changes of body mass,alanine aminotransferase(ALT),aspartate aminotransferase (AST),total cholesterol (TC),triglyceride (TG),glucose (GLU) and prolactin (PRL) were detected and compared between before and after treatment.Results The body mass after medication in children patients was significantly increased,average increase by (3.50-t-1.90)kg (P＜0.01).The levels of ALT,AST,TC,TG and PRL after treatment were higher than before treatment (P＜0.05).However,there was no statistically significant difference in blood GLU level between before and after treatment(P=0.598).The body mass change before and after treatment was positively correlated with ALT and AST levels(r=0.366,0.377,P＜0.05);whereas the PRL level before and after treatment was negatively correlated with the body mass change (r=-0.432,P＜0.01).Conclusion Olanzapine can lead to the body weight gain and increase of ALT,AST,TC,TG and PRL levels in COS patients.
